RENVA covers longevity telehealth providers with independent pricing research and comparison guides. All affiliate relationships are disclosed. No medical advice.
What a peptide actually is, the major categories you'll encounter, and the three questions worth asking about any specific peptide before you research further.
A July 2026 FDA advisory vote is reshaping this landscape in real time. Here's what's actually approved, what isn't, and what that vote does and doesn't mean today.
From intake to e-prescribing to your medication shipping out — here's what actually happens behind the scenes of a telehealth longevity visit.
For testosterone therapy specifically, a real, established monitoring protocol exists. Here's what a well-run longevity program should actually be checking, and when.
Most longevity treatments are compounded, not FDA-approved. Here's what that actually means legally, what oversight looks like, and what questions to ask before starting.
Licensing, prescribing rules, and consumer protections a legitimate longevity telehealth provider should already have in place — illustrated by a real 2025 FTC enforcement case.
Both are GHRH analogs that stimulate your own growth hormone — but their regulatory status and evidence base are genuinely different. Here's the real comparison.
NAD+ delivery routes aren't interchangeable. Here's what's actually been studied in humans for injection, IV, and nasal spray — and where the evidence runs out.
No official source tracks NAD+ pricing, and it changes often. Here's what actually drives the cost difference between providers — plus a live, current comparison.
NAD+ and sermorelin support two different biological systems, not two competing treatments. Here's how to think about which one fits what you're actually trying to support.
A mechanistically novel compound with consistently positive animal research behind it — here's what the science shows and where human research currently stands.
B12 injections are safe and genuinely effective for people with a real deficiency. Here's the honest, NIH-backed answer on what they do for everyone else.
The trial designed to test whether metformin extends healthy human lifespan has been ready since 2016 and still hasn't enrolled a single participant. Here's what the evidence actually shows.
Rapamycin has the strongest animal lifespan evidence of any longevity compound — but the human evidence is limited to one 48-week safety trial. Here's the honest gap between the two.
Methylene blue's mitochondrial mechanism and early cognition research, plus the FDA boxed-warning drug interaction that matters more than the marketing suggests.
LDN's fibromyalgia evidence has gotten weaker as the trials have gotten bigger — including a major 2026 study that found no benefit over placebo. Here's the full trajectory.
Tesamorelin's actual FDA approval is much narrower than how it's marketed for longevity — here's what's approved, what's been studied for cognition, and what's still genuinely uncertain.
What sermorelin actually does, its real FDA history, and an honest look at the body-composition and sleep evidence — including a finding that contradicts common marketing claims.
A plain-language guide to NAD+ therapy — what the research actually shows, how the delivery formats differ, and what to know before you pay for it.
Affiliate disclosure: RENVA may earn affiliate commissions from some provider links. Affiliate relationships do not influence provider scoring or editorial conclusions. Full disclosure →
Medical disclaimer: RENVA is not a healthcare provider. Content is informational and educational only. Always consult a licensed healthcare professional before making health decisions. Full disclaimer →